Using Digital Solutions to Improve Heart Failure Treatment
Author Information
Author(s): Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R. Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill
Primary Institution: University of Twente
Hypothesis
Can digital solutions optimize guideline-directed medical therapy (GDMT) prescription rates in heart failure patients?
Conclusion
Digital solutions can significantly enhance the prescription rates of guideline-directed medical therapy for heart failure patients.
Supporting Evidence
- Digital solutions can help clinicians see more patients efficiently.
- Remote monitoring provides valuable data for optimizing treatment.
- Clinical decision support systems can alert clinicians to medication needs.
- Digital consults can improve patient access to care.
- Studies show that digital interventions can increase GDMT prescription rates.
- Multifaceted digital solutions are more effective than standalone interventions.
- Patient engagement tools can enhance adherence to treatment.
- Digital health technologies have gained popularity during the COVID-19 pandemic.
Takeaway
Doctors can use technology to help patients with heart failure get the right medicines more easily, which can make them feel better.
Methodology
The study reviews various digital solutions and their effectiveness in optimizing GDMT for heart failure patients, including data from the EVOLUTION HF study.
Potential Biases
Potential biases include clinician skepticism towards digital tools and variability in patient access to technology.
Limitations
The study highlights the variability in healthcare infrastructure and clinician practices that may affect the implementation of digital solutions.
Participant Demographics
The study includes heart failure patients from various countries, with a focus on those with reduced ejection fraction.
Statistical Information
P-Value
0.01
Confidence Interval
95% confidence interval: 0.31–0.49
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website